Similar articles

• India's IP snub.

  Jayaraman KS. Jayaraman KS. Nat Biotechnol. 2008 Apr;26(4):362. doi: 10.1038/nbt0408-362b. Nat Biotechnol. 2008. PMID: 18392000 No abstract available.
• Cabilly patent finale.

  Waltz E. Waltz E. Nat Biotechnol. 2008 Aug;26(8):846. doi: 10.1038/nbt0808-846b. Nat Biotechnol. 2008. PMID: 18688222 No abstract available.
• A license to print money?

  [No authors listed] [No authors listed] Nat Biotechnol. 2006 Jun;24(6):593. doi: 10.1038/nbt0606-593. Nat Biotechnol. 2006. PMID: 16763570 No abstract available.
• Patentability issues surrounding antivirals.

  Lu DL, Collison AM, Kowalski TJ. Lu DL, et al. Nat Biotechnol. 2007 Dec;25(12):1403-4. doi: 10.1038/nbt1207-1403. Nat Biotechnol. 2007. PMID: 18066035 Review. No abstract available.
• The North American Free Trade Agreement's effect on pharmaceutical patents: a bitter pill to swallow or a therapeutic solution?

  Silbermann JM. Silbermann JM. J Contemp Health Law Policy. 1996 Spring;12(2):607-36. J Contemp Health Law Policy. 1996. PMID: 8666736 Review. No abstract available.